European Journal of Pharmaceutical and Medical Research (EJPMR) Peer review process ensures that the quality Journal publishes good science which is of benefit to whole scientific community. Peer review is an integral part of scientific publication that confirms the authenticity of the science reported.

After receiving a new manuscript, the editorial office will evaluate the article to confirm that the article is authentic, complete, ethically approved, correctly formatted, original research work, innovative, significance to the field, under the scope of the Journal, in the style of a scientific article and written in English language. If article has problems with any of the above criteria may be rejected.

Double-Blind Peer Review Process

Once an article manuscript is deemed suitable by the Editor(s)-in-Chief we follow the double-blind peer review process.

In Double blind review process neither authors nor reviewers know each other's identities.

Reviewers are given evaluation criteria and asked to provide comments to the author if any and may also provide feedback confidentially to the Editor office.

Reviewers evaluate a manuscript for Originality and significance of contribution, Satisfactoriness of methodology, analysis, and comprehension, Interest to research community and International relevance.

Once all reviews have been received, the Editor(s)-in-Chief, make reviews available to the author(s) and the comments to the author(s) of the manuscript

If the manuscript is accepted, then the author will be provided with the formatting guidelines for final submission. If the manuscript requires substantial revisions, then the author will be expected to follow the reviewer’s commentary and also the formatting guidelines for the re-submission of the manuscript. If the manuscript is rejected, then the process ends.